Home | Sitemap | Submit Content | Contact Us   
imageHome : Latest News : APRISO(TM) Granted FDA Marketing Approval for Maintenance of Remission ... - MSN MoneyCentral

APRISO(TM) Granted FDA Marketing Approval for Maintenance of Remission ... - MSN MoneyCentral

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service121 times read : Adjust font size: Decrease font Enlarge font
image

Salix Pharmaceuticals, Ltd. SLXP today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for APRISO ™ (mesalamine) extended-release capsules 0.375 g. APRISO is a locally-acting aminosalicylate indicated for ...

Read this article...



Post your comment comment Comments (0 posted)

copyright